Acurx Pharmaceuticals, LLC Business Finance Contracts & Agreements
18 Contracts & Agreements
- Investor Rights Agreements (1 contract)
- Purchase Agreements (5)
- Stock Agreements (1)
- Underwriting Agreements (2)
- Warrant Agreements (9)
- Form of Securities Purchase Agreement, dated as of May 16, 2023, by and between the Company and the 2023 Investor (Filed With SEC on August 11, 2023)
- Form of Securities Purchase Agreement, dated as of May 16, 2023, by and between Acurx Pharmaceuticals, Inc. and the Investor (Filed With SEC on May 17, 2023)
- Form of Pre-Funded Warrant (Filed With SEC on May 17, 2023)
- Form of Series D Warrant (Filed With SEC on May 17, 2023)
- Form of Series C Warrant (Filed With SEC on May 17, 2023)
- Form of Securities Purchase Agreement, dated as of July 25, 2022, by and among Acurx Pharmaceuticals, Inc. and the purchasers party thereto (Filed With SEC on July 25, 2022)
- Form of Placement Agent Warrant (Filed With SEC on July 25, 2022)
- Form of Pre-Funded Warrant (Filed With SEC on July 25, 2022)
- Form of Series B Warrant (Filed With SEC on July 25, 2022)
- Form of Series A Warrant (Filed With SEC on July 25, 2022)
- Form of Underwriting Agreement (Filed With SEC on June 11, 2021)
- Asset Purchase Agreement, dated February 5, 2018, by and between the Registrant and GLSynthesis Inc (Filed With SEC on May 27, 2021)
- Form of Investor Rights Agreement, by and between the Registrant and certain purchasers (Filed With SEC on May 27, 2021)
- Form of Common Stock Purchase Warrant (Filed With SEC on May 27, 2021)
- Form of Warrant (Filed With SEC on May 27, 2021)
- Form of Securities Purchase Agreement (Filed With SEC on May 27, 2021)
- Form of Common Stock Certificate (Filed With SEC on May 27, 2021)
- Form of Underwriting Agreement (Filed With SEC on May 27, 2021)
